Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Nina Singh, MD
University of Pittaburgh, VA Pittsburgh Health Systems
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ucla Medical Cente
Los Angeles, California, United States
- University of Miami
Miami, Florida, United States
- University of Michigan
Ann Arbor, Michigan, United States
- University of Pittsburgh
Pittsburgh, Pennsylvania, United States
- University of Washington Medical Center
Seattle, Washington, United States
- University of Wisconsin - Madison
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2010
- Primary completion
- 31 Jul 2013
- Completion
- 31 May 2014
- Last update posted
- 17 Dec 2014
- Registered enrollment
- 200
- Registry id
- NCT00841971
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.